David Levine, Chairman of the Board of Directors of the Quebec Network for Personalized Health Care (QNPHC) is pleased to announce the appointment of Michelle Savoie as Chief …Read More
The next board of directors’ meeting of the QNPHC will be held on November 21st.
The QNPHC and Genome Quebec are almost ready to launch “Genomic 101″ training course for health professionals in order to raise their awareness of the subject and the …Read More
QNPHC’s Chairman of the Board, David Levine, is pleased to announce the nomination of a new member of the board, Mrs Alexandra Obadia, General manager of CARTaGENE.
QNPHC’s Chairman of the Board, David Levine,is pleased to announce that Merck Canada decided to continue its financial contribution for the next three years.
Mr. Carl Viel, CEO of Québec International, is now part of QNPHC’s board of directors, representing Biopolis
QNPHC got a subsidy from the MEIE (Economy, Innovation and Exports) to meet a significant issue for companies in the sector of life science : i.e. the …Read More
The Board of Directors of the QNPHC is pleased to announce that Merck Canada Inc. has renewed its financial support for the next three years.
The QNPHC as well as several organizations dedicated to the PHC through Canada showed their interest in the creation of a Canada-wide network to promote PHC and …Read More
Mr. Carl Viel, CEO of Québec International, is now part of the QNPHC’s board, representing Biopolis.